Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-18-042319

Options or other derivatives

  • Director acquired 158,233 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Duncan Barbara Gayle Director 2018-06-22 Grant or award · Option to purchase Ordinary Shares +158,233 158,233 D
Loading xslF345X03/a4.xml…